Zobrazeno 71 - 80
of 575
pro vyhledávání: '"Yucai Wang"'
Autor:
Sanjal H. Desai, Raphael Mwangi, Wern Lynn Ng, Rebecca L. King, Matthew J. Maurer, James R. Cerhan, Andrew L. Feldman, Umar Farooq, Eric Mou, Thomas M. Habermann, Carrie A. Thompson, Yucai Wang, Thomas E. Witzig, Grzegorz S. Nowakowski
Publikováno v:
Blood Advances. 6:6180-6186
An enhanced understanding of the molecular heterogeneity of diffuse large B-cell lymphoma (DLBCL) has opened the door to clinical trials evaluating novel agents with subtype-specific activity. It is an emerging question whether core needle biopsies (
Autor:
Darragh F. O'Donoghue, Huong L. Truong, Heidi D. Finnes, Jennifer S. McDonald, Heather P. May, Stephen M. Ansell, N. Nora Bennani, Thomas M. Habermann, David J. Inwards, Patrick B. Johnston, Arushi Khurana, Yi Lin, Ivana N. Micallef, Grzegorz S. Nowakowski, Jonas Paludo, Luis F. Porrata, Gita Thanarajasingam, Carrie A. Thompson, Jose C. Villasboas, Yucai Wang, Thomas E. Witzig, Nelson Leung
Publikováno v:
JCO Oncology Practice. 18:e1908-e1917
PURPOSE: High-dose methotrexate (HDMTX; > 500 mg/m2) is an important component of lymphoma therapy. Serum MTX monitoring at 48 hours is the standard approach to identify those at increased risk of developing MTX toxicity. Our aim was to characterize
Autor:
Nicole McLaughlin, Yucai Wang, Thomas Witzig, Jose Villasboas, Thomas Habermann, David Inwards, Nora Bennani, Gita Thanarajasingam, Grzegorz Nowakowski, Luis Porrata, Carrie Thompson, Ivana Micallef, Patrick Johnston, Stephen Ansell, Jonas Paludo
Publikováno v:
Leukemia & Lymphoma. 64:371-377
Involvement of the central nervous system (CNS) is a rare complication of mantle cell lymphoma (MCL) with limited treatment options. We report the outcomes of 36 patients with CNS involvement compared to 72 matched control MCL patients without CNS in
Autor:
Michael L. Wang, Nirav N. Shah, Wojciech Jurczak, Pier Luigi Zinzani, Toby A. Eyre, Chan Y. Cheah, Chaitra S. Ujjani, Youngil Koh, Koji Izutsu, James N. Gerson, Ian W. Flinn, Benoit Tessoulin, Alvaro J. Alencar, Shuo Ma, Ewa Lech-Marańda, Joanna M. Rhodes, Krish Patel, Jennifer A. Woyach, Nicole Lamanna, Yucai Wang, Constantine S. Tam, John F. Seymour, Talha Munir, Hirokazu Nagai, Francisco Hernandez-Ilizaliturri, Anita Kumar, Andrew D. Zelenetz, Preetesh Jain, Binoj Nair, Donald E. Tsai, Minna Balbas, Richard A. Walgren, Paolo B. Abada, Chunxiao Wang, Junjie Zhao, Anthony R. Mato
Publikováno v:
Blood. 140:9368-9372
Autor:
Sanjal H. Desai, Raphael Mwangi, Alexandra N. Smith, Matthew J. Maurer, Umar Farooq, Rebecca L. King, James R. Cerhan, Andrew L. Feldman, Thomas M. Habermann, Carrie A. Thompson, Yucai Wang, Stephen M. Ansell, Thomas E. Witzig, Grzegorz S. Nowakowski
Publikováno v:
Hematological Oncology. 41:39-49
Activated B cell (ABC) type diffuse large B cell lymphoma (DLBCL), double hit lymphoma (DHL) and double expressor lymphoma (DEL) have poor outcomes to frontline R-CHOP but impact of these molecular features on outcomes of relapsed/refractory (R/R) di
Autor:
Toby A Eyre, Nirav N Shah, Martin Dreyling, Wojciech Jurczak, Yucai Wang, Chan Y Cheah, Yuqin Song, Mitul Gandhi, Christopher Chay, Jeff Sharman, David J Andorsky, Hannah M Messersmith, Amy S Ruppert, Valerie A Muthig, Rodrigo Ito, Michael L Wang
Publikováno v:
Future Oncology. 18:3961-3969
Treatment with covalent Bruton tyrosine kinase inhibitors (BTKi) represents an important advance in the management of relapsed or refractory mantle cell lymphoma, but these treatments are not curative and many patients ultimately relapse. Pirtobrutin
Publikováno v:
Current Treatment Options in Oncology. 23:1614-1625
For years, upfront autologous hematopoietic cell transplant (auto-HCT) has been the standard of care for younger and physically fit mantle cell lymphoma (MCL) patients after chemoimmunotherapy (CIT) induction. Bruton's tyrosine kinase (BTK) inhibitor
Autor:
Aung M. Tun, Seth Maliske, Yucai Wang, David J. Inwards, Thomas M. Habermann, Ivana Micallef, Luis Porrata, Jonas Paludo, Jose Villasboas Bisneto, Allison Rosenthal, Mohamed A Kharfan-Dabaja, Stephen M. Ansell, Grzegorz S. Nowakowski, Umar Farooq, Patrick B. Johnston
Publikováno v:
Transplantation and Cellular Therapy. 28:610-617
Patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) who achieve progression-free survival (PFS) at 24 months (PFS24) after immunochemotherapy (IC) have excellent overall survival (OS) comparable to that of the age- and sex-matched gen
Publikováno v:
Nano Letters. 22:6877-6887
Intracellular transcytosis can enhance the penetration of nanomedicines to deep avascular tumor tissues, but strategies that can improve transcytosis are limited. In this study, we discovered that pyknomorphic extracellular matrix (ECM) is a shield t
Autor:
Naba Farooqui, Janina Paula T. Sy-Go, Jing Miao, Ramila Mehta, Lisa E. Vaughan, N. Nora Bennani, Yucai Wang, Radhika Bansal, Matthew A. Hathcock, Suzanne R. Hayman, Patrick B. Johnston, Jose C. Villasboas, Jonas Paludo, Stephen M. Ansell, Nelson Leung, Yi Lin, Sandra M. Herrmann
Publikováno v:
Mayo Clinic Proceedings. 97:1294-1304